Prediction of prevalent but not incident non-alcoholic fatty liver disease by levels of serum testosterone

Low serum sex hormone-binding globulin is associated with nonalcoholic fatty liver disease in type 2 diabetic patients

(2013) Xiaomin Hua et al.   CLINICAL ENDOCRINOLOGY

Testosterone Replacement Ameliorates Nonalcoholic Fatty Liver Disease in Castrated Male Rats

(2013) L. Nikolaenko et al.   ENDOCRINOLOGY

Testosterone: a metabolic hormone in health and disease

(2013) Daniel M Kelly et al.   JOURNAL OF ENDOCRINOLOGY

Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: Results of a US national survey in three ethnic groups

(2013) Mark M Smits et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Decreased Serum Testosterone Levels in Long-Term Adult Survivors with Fatty Liver after Childhood Stem Cell Transplantation

(2012) Hiromi Hyodo et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease

(2012) Sunmi Kim et al.   BMC GASTROENTEROLOGY

Total testosterone may not decline with ageing in Korean men aged 40 years or older

(2012) Young-Sang Kim et al.   CLINICAL ENDOCRINOLOGY

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

(2012) Naga Chalasani et al.   HEPATOLOGY

The epidemiology, pathogenesis and histopathology of fatty liver disease

(2012) Adam P Levene et al.   HISTOPATHOLOGY

Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus

(2012) Anuradhani Kasturiratne et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Total testosterone and sex hormone-binding globulin are associated with metabolic syndrome independent of age and body mass index in Korean men

(2012) Doohee Hong et al.   MATURITAS

Dyslipidemia in Patients with Nonalcoholic Fatty Liver Disease

(2012) Hemant Chatrath et al.   SEMINARS IN LIVER DISEASE

The role of sex hormone-binding globulin and testosterone in the risk of incident metabolic syndrome

(2012) Robin Haring et al.   European Journal of Preventive Cardiology

Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008

(2011) Zobair M. Younossi et al.   Clinical Gastroenterology and Hepatology

Sex Hormone-Binding Globulin, but Not Testosterone, Is Associated Prospectively and Independently With Incident Metabolic Syndrome in Men: The Framingham Heart Study

(2011) S. Bhasin et al.   DIABETES CARE

Serum sex hormone-binding globulin levels are independently associated with nonalcoholic fatty liver disease in people with type 2 diabetes

(2011) Jang Yel Shin et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease

(2011) N. Kumashiro et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Prevalence, incidence and risk factors of testosterone deficiency in a population-based cohort of men: results from the study of health in Pomerania

(2010) Robin Haring et al.   Aging Male

Assessment of Hepatic Steatosis in Patients Undergoing Liver Resection: Comparison of US, CT, T1-weighted Dual-Echo MR Imaging, and Point-resolved1H MR Spectroscopy

(2010) Jochem R. van Werven et al.   RADIOLOGY

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

(2009) Kittichai Promrat et al.   HEPATOLOGY

Hepatic steatosis is associated with low serum testosterone and high serum DHEAS levels in men

(2009) Henry Völzke et al.   INTERNATIONAL JOURNAL OF ANDROLOGY

Hypothalamic-Pituitary-Testicular Axis Disruptions in Older Men Are Differentially Linked to Age and Modifiable Risk Factors: The European Male Aging Study

(2008) Frederick C. W. Wu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM